Sponsored by: Urocor Inc.

If you are a man over 40, you should have an annual check-up and screening for Prostate Cancer. The American Cancer Society estimates that there are about 245,000 new cases of Prostate Cancer every year. It is the second leading cause of cancer death in males, and each year it claims about 40,000 lives. The real tragedy is that Prostate Cancer is now a very treatable disease in most stages, and if detected and diagnosed in the earliest stage, it can actually be cured. Fortunately, innovative diagnostic tests and detection techniques are now available to give doctors the tools they need to identify Prostate Cancer at an earlier stage than they could in the past. Pioneering companies, like UroCor, market, develop, and advance state-of-the-art diagnostic testing so that Prostate Cancer can now be detected at a time when a man can have many alternatives and an excellent chance for a very positive outcome. UroCor’s Serum-Total PSA, Free/Total PSA Ratio, the UroScore-Staging Algorithm, and DNA Ploidy Analysis system are all powerful examples of innovative tools doctors now have to diagnose, stage, and treat Prostate Cancer better than ever before.